vs
Side-by-side financial comparison of InvenTrust Properties Corp. (IVT) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $77.4M, roughly 1.1× InvenTrust Properties Corp.). InvenTrust Properties Corp. runs the higher net margin — 3.4% vs -38.1%, a 41.5% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 8.6%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 7.6%).
InvenTrust Properties Corp. is a real estate investment trust that invests in shopping malls. As of December 31, 2024, the company owned interests in 68 properties comprising 11.0 million square feet.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
IVT vs PRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $77.4M | $83.1M |
| Net Profit | $2.7M | $-31.6M |
| Gross Margin | — | 64.9% |
| Operating Margin | -11.0% | -4.1% |
| Net Margin | 3.4% | -38.1% |
| Revenue YoY | 8.6% | 20.2% |
| Net Profit YoY | -72.8% | -27.9% |
| EPS (diluted) | $0.02 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $77.4M | $76.4M | ||
| Q3 25 | $74.5M | $83.3M | ||
| Q2 25 | $73.6M | $79.2M | ||
| Q1 25 | $73.8M | $69.2M | ||
| Q4 24 | $71.2M | $68.2M | ||
| Q3 24 | $68.5M | $58.4M | ||
| Q2 24 | $67.4M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $2.7M | $-29.8M | ||
| Q3 25 | $6.0M | $-21.4M | ||
| Q2 25 | $95.9M | $-19.6M | ||
| Q1 25 | $6.8M | $-24.7M | ||
| Q4 24 | $9.8M | $-18.9M | ||
| Q3 24 | $-539.0K | $-21.0M | ||
| Q2 24 | $1.5M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | -11.0% | -40.6% | ||
| Q3 25 | -9.8% | -27.8% | ||
| Q2 25 | — | -28.0% | ||
| Q1 25 | -10.5% | -39.7% | ||
| Q4 24 | -3.6% | -28.9% | ||
| Q3 24 | -18.7% | -38.4% | ||
| Q2 24 | -13.6% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | 3.4% | -39.1% | ||
| Q3 25 | 8.1% | -25.7% | ||
| Q2 25 | 130.4% | -24.7% | ||
| Q1 25 | 9.2% | -35.8% | ||
| Q4 24 | 13.8% | -27.6% | ||
| Q3 24 | -0.8% | -35.9% | ||
| Q2 24 | 2.2% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $0.02 | $-0.54 | ||
| Q3 25 | $0.08 | $-0.38 | ||
| Q2 25 | $1.23 | $-0.35 | ||
| Q1 25 | $0.09 | $-0.45 | ||
| Q4 24 | $0.14 | $-0.34 | ||
| Q3 24 | $-0.01 | $-0.40 | ||
| Q2 24 | $0.02 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $245.6M |
| Total DebtLower is stronger | $825.9M | $51.7M |
| Stockholders' EquityBook value | $1.8B | $347.7M |
| Total Assets | $2.8B | $487.1M |
| Debt / EquityLower = less leverage | 0.46× | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | — | $286.5M | ||
| Q3 25 | — | $294.3M | ||
| Q2 25 | — | $302.7M | ||
| Q1 25 | — | $316.2M | ||
| Q4 24 | — | $333.7M | ||
| Q3 24 | — | $196.8M | ||
| Q2 24 | — | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | $825.9M | $51.6M | ||
| Q3 25 | $764.6M | $51.6M | ||
| Q2 25 | $746.3M | $51.5M | ||
| Q1 25 | $740.7M | $51.5M | ||
| Q4 24 | $740.4M | $51.5M | ||
| Q3 24 | $740.1M | $51.4M | ||
| Q2 24 | $812.2M | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $1.8B | $365.9M | ||
| Q3 25 | $1.8B | $380.3M | ||
| Q2 25 | $1.8B | $385.8M | ||
| Q1 25 | $1.7B | $389.2M | ||
| Q4 24 | $1.8B | $402.2M | ||
| Q3 24 | $1.8B | $241.2M | ||
| Q2 24 | $1.5B | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $2.8B | $508.1M | ||
| Q3 25 | $2.7B | $511.5M | ||
| Q2 25 | $2.7B | $513.1M | ||
| Q1 25 | $2.6B | $519.4M | ||
| Q4 24 | $2.6B | $534.0M | ||
| Q3 24 | $2.6B | $374.1M | ||
| Q2 24 | $2.5B | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | 0.46× | 0.14× | ||
| Q3 25 | 0.42× | 0.14× | ||
| Q2 25 | 0.41× | 0.13× | ||
| Q1 25 | 0.42× | 0.13× | ||
| Q4 24 | 0.42× | 0.13× | ||
| Q3 24 | 0.42× | 0.21× | ||
| Q2 24 | 0.53× | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $155.4M | — |
| Free Cash FlowOCF − Capex | $110.9M | — |
| FCF MarginFCF / Revenue | 143.3% | — |
| Capex IntensityCapex / Revenue | 57.5% | — |
| Cash ConversionOCF / Net Profit | 58.41× | — |
| TTM Free Cash FlowTrailing 4 quarters | $193.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $155.4M | $-10.3M | ||
| Q3 25 | $43.8M | $-6.6M | ||
| Q2 25 | $48.7M | $-15.0M | ||
| Q1 25 | $20.2M | $-17.0M | ||
| Q4 24 | $136.9M | $-32.4M | ||
| Q3 24 | $38.4M | $-18.8M | ||
| Q2 24 | $46.7M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | $110.9M | $-12.2M | ||
| Q3 25 | $31.4M | $-9.5M | ||
| Q2 25 | $38.0M | $-17.8M | ||
| Q1 25 | $12.8M | $-18.8M | ||
| Q4 24 | $100.8M | $-33.6M | ||
| Q3 24 | $29.3M | $-19.0M | ||
| Q2 24 | $37.2M | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | 143.3% | -15.9% | ||
| Q3 25 | 42.2% | -11.4% | ||
| Q2 25 | 51.6% | -22.5% | ||
| Q1 25 | 17.4% | -27.2% | ||
| Q4 24 | 141.5% | -49.2% | ||
| Q3 24 | 42.8% | -32.6% | ||
| Q2 24 | 55.2% | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | 57.5% | 2.4% | ||
| Q3 25 | 16.7% | 3.4% | ||
| Q2 25 | 14.6% | 3.5% | ||
| Q1 25 | 10.0% | 2.7% | ||
| Q4 24 | 50.7% | 1.7% | ||
| Q3 24 | 13.3% | 0.4% | ||
| Q2 24 | 14.0% | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | 58.41× | — | ||
| Q3 25 | 7.27× | — | ||
| Q2 25 | 0.51× | — | ||
| Q1 25 | 2.97× | — | ||
| Q4 24 | 13.97× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 31.15× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IVT
Segment breakdown not available.
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
